IL-35 expression in peripheral blood CD4+ T cells from chronic hepatitis B virus-infected patients directly correlates with virus load

Cytokine

Volumn 73, Issue 1, 2015, Pages 169-175

  Zhou, Yali ^a   Zhang, Hong ^a   Li, Yumin ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

CD4+ T cell; Chronic hepatitis B; IL 35; Viral load

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS INDUCED 3 PROTEIN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; INTERLEUKIN 35; MESSENGER RNA; PROTEIN P35; UNCLASSIFIED DRUG; VIRUS DNA; EBI3 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-35, HUMAN;

ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOREGULATION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; UPREGULATION; VIRUS LOAD; ADULT; BLOOD; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOLOGY; LIVER; LYMPHOCYTE COUNT; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VIROLOGY;

HEPATITIS B VIRUS;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERLEUKINS; LIVER; LIVER FUNCTION TESTS; LYMPHOCYTE COUNT; MALE; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; VIRAL LOAD;

EID: 84924112946     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.02.003     Document Type: Article

References (34)

1. Devergne O., Birkenbach M., Kieff E. Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci USA 1997, 94:12041-12046.
2. Devergne O., Hummel M., Koeppen H., Le Beau M.M., Nathanson E.C., Kieff E., et al. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol 1996, 70:1143-1153.
3. Collison L.W., Workman C.J., Kuo T.T., Boyd K., Wang Y., Vignali K.M., et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007, 450:566-569.
4. Bardel E., Larousserie F., Charlot-Rabiega P., Coulomb-L'Herminé A., Devergne O. Human CD4+ CD25+ Foxp3+ regulatory T cells do not constitutively express IL-35. J Immunol 2008, 181:6898-6905.
5. Liu F., Tong F., He Y., Liu H. Detectable expression of IL-35 in CD4+ T cells from peripheral blood of chronic hepatitis B patients. Clin Immunol 2011, 139:1-5.
6. Ott J.J., Stevens G.A., Groeger J., Wiersma S.T. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012, 30:2212-2219.
7. Feng X., Yan H.P., Liao H.Y., Liu Y.M., Zhang G.Y., Lin F., et al. The characteristic of T cells response to HBV-specific antigen proteins in patients with HBV infection. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2012, 26:253-255.
8. Xu D., Fu J., Jin L., Zhang H., Zhou C., Zou Z., et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the anti-viral immune response and disease progression in patients with hepatitis B. J Immunol 2006, 177:739-747.
9. Chinese society of infectious diseases and parasitology and chinese society of hepatology of chinese medical association. The programme of prevention and cure for viral hepatitis. Zhonghua Ganzangbin Zazhi. Chinese J Hepatol 2000; 8: 324-9.
10. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
11. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004, 22:531-562.
12. Jiang H., Chess L. An integrated view of suppressor T cell subsets in immunoregulation. J Clin Invest 2004, 114:1198-1208.
13. Piccirillo C.A., Thornton A.M. Cornerstone of peripheral tolerance. Naturally occurring CD4+CD25+ regulatory T cells. Trends Immunol 2004, 25:374-380.
14. Franzese O., Kennedy P.T., Gehring A.J., Gotto J., Williams R., Maini M.K., et al. Modulation of the CD8+ T-cell response by CD4+CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol 2005, 79:3322-3328.
15. Stoop J.N., van der Molen R.G., Baan C.C., van der Laan L.J., Kuipers E.J., Kusters J.G., et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005, 41:771-778.
16. Collison L.W., Pillai M.R., Chaturvedi V., Vignali D.A. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J Immunol 2009, 182:6121-6128.
17. Huang C.H., Loo E.X., Kuo I.C., Soh G.H., Goh D.L., Lee B.W., et al. Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35. J Immunol 2011, 187:462-471.
18. Wirtz S., Billmeier U., Mchedlidze T., Blumberg R.S., Neurath M.F. Interleukin-35 mediates mucosal immune responses that protect against T-cell dependent colitis. Gastroenterology 2011, 141:1875-1886.
19. Whitehead G.S., Wilson R.H., Nakano K., Burch L.H., Nakano H., Cook D.N. IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J Allergy Clin Immunol 2012, 129:207-215.
20. Niedbala W., Wei X.Q., Cai B., Hueber A.J., Leung B.P., McInnes I.B., et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 2007, 37:3021-3029.
21. Yang J., Yang M., Htut T.M., Ouyang X., Hanidu A., Li X., et al. Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORgamma t. Eur J Immunol 2008, 38:1204-1214.
22. Liu J.Q., Liu Z., Zhang X., Shi Y., Talebian F., Carl J.W., et al. Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis. J Immunol 2012, 188:3099-3106.
23. He D.M., Yan G.H., Wang Y.M. Serum levels of interleukin-12 in various clinical states with hepatitis B virus infection. Cell Immunol 2012, 272:162-165.
24. Zhu C.L., Zhang R., Liu L., Rasool S.T., Mu Y.X., Sun W., et al. Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro. Clin Immunol 2009, 131:92-97.
25. Xia L.M., Tian D.A., Huang W.J., Zhu H.W., Wang J., Zhang Y.G., et al. Upregulation of IL-23 expression in patients with chronic hepatitis B is mediated by the HBx/ERK/NF-kB pathway. J Immunol 2012, 188:753-764.
26. Terayama H., Yoshimoto T., Hirai S., Naito M., Qu N., Hatayama N., et al. Contribution of IL-12/IL-35 common subunit p35 to maintaining the testicular immune privilege. PLoS One 2014, 9:e96120.
27. Mao H.T., Gao W.J., Ma C., Sun J.T., Liu J., Shao Q.Q., et al. Human placental trophoblasts express the immunosuppressive cytokine IL-35. Hum Immunol 2013, 74:872-877.
28. Wong CK, Leung TF, Chu IM, Dong J, Lam YY, Lam CW. Aberrant Expression of Regulatory Cytokine IL-35 and Pattern Recognition Receptor NOD2 in Patients with Allergic Asthma. Inflammation 2014; Oct 18.
29. Mitani A., Niedbala W., Fujimura T., Mogi M., Miyamae S., Higuchi N., et al. Increased Expression of Interleukin-35 and -17, but not -27, in Gingival Tissues With Chronic Periodontitis. J Periodontol 2014, 1-15.
30. Wu H., Li P., Shao N., Ma J., Ji M., Sun X., et al. Aberrant expression of Treg-associated cytokine IL-35 along with IL-10 and TGF-β in acute myeloid leukemia. Oncol Lett 2012, 3:1119-1123.
31. Guttek K., Reinhold D. Stimulated human peripheral T cells produce high amounts of IL-35 protein in a proliferation-dependent manner. Cytokine 2013, 64:46-50.
32. Longhi M.S., Ma Y., Mitry R.R., Bogdanos D.P., Heneghan M., Cheeseman P., et al. Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun 2005, 25:63-71.
33. Longhi M.S., Ma Y., Bogdanos D.P., Cheeseman P., Mieli-Vergani G., Vergani D. Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 2004, 41:31-37.
34. Chisari F.V., Isogawa M., Wieland S.F. Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris) 2010, 58:258-266.